Novo Nordisk A/S (NVO)

NYQ – Real Time Price. Currency in USD

47.00

+0.60 (1.29%)

At close: May 12, 2026, 4:00 PM EDT

47.01

+0.01 (0.02%)

After-hours: May 12, 2026, 7:58 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

46.74B

42.12B

33.70B

25B

Cost of goods sold

-9.19B

-6.80B

-5.63B

-4.38B

Gross Profit

37.55B

35.31B

28.07B

20.62B

Operating expenses (excl. COGS)

-17.13B

-15.10B

-13.07B

-10.11B

Operating Income

20.42B

20.22B

15B

10.51B

Non-operating income, total

-676M

-1.77B

175M

-730M

Pretax income

19.74B

18.45B

15.18B

9.78B

Equity in earnings

-1M

12M

-27M

Taxes

-4.25B

-3.80B

-3.05B

-1.91B

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

15.49B

14.65B

12.14B

7.84B

Novo Nordisk A/S (NVO)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Novo Nordisk A/S (NVO)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Novo Nordisk A/S (NVO)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Novo Nordisk A/S (NVO)

Income Statement (Annual)

Income Statement (Annual)